Big Gain For Chemomab Therapeutics Ltd.
Thu, Jul 02, 2026 at 07:48 PM
Chemomab Therapeutics Ltd. (CMMB:NASDAQ) jumped higher at $2.27, a gain of 33.5%. On Thu, Jul 02, 2026, CMMB:NASDAQ touched a New 2-Week High of $2.27. The stock got featured on our News Catalysts scanner on Fri, Jun 19, 2026 at 03:12 AM in the 'BIOTECH' category. From Thu, Jun 18, 2026, the stock recorded 66.67% Up Days and 70.00% Green Days
About Chemomab Therapeutics Ltd. (CMMB:NASDAQ)
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need.
Top 10 Gainers:
- ClearOne, Inc. (CLRO:NASDAQ), 101.24%
- CaliberCos Inc. (CWD:NASDAQ), 90.61%
- Yiren Digital Ltd. (YRD:NYSE), 59.68%
- Big Tree Cloud Holdings Limited (DSY:NASDAQ), 56.84%
- SL Science Holding Limited (SLBT:NASDAQ), 34.61%
- Hongli Group Inc. (HLP:NASDAQ), 34.41%
- StablecoinX Inc. (USDE:NASDAQ), 33.65%
- Chemomab Therapeutics Ltd. (CMMB:NASDAQ), 33.53%
- CCSC Technology International Holdings Limited (CCTG:NASDAQ), 28.53%
- Brenmiller Energy Ltd (BNRG:NASDAQ), 27.21%